tibolone has been researched along with endothelin-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byrne, DJ; Ginsburg, J; Jagroop, IA; Kwong, P; Mikhailidis, DP; Prelevic, GM | 1 |
| Ciaponi, M; Fini, M; Gambacciani, M; Genazzani, AR; Mercuro, G; Monteleone, P; Rosano, GM; Silvestri, A; Vitale, C | 1 |
1 trial(s) available for tibolone and endothelin-1
| Article | Year |
|---|---|
Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
Topics: Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Dehydroepiandrosterone; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Forearm; Humans; Medroxyprogesterone; Middle Aged; Nitrates; Nitrites; Nitroglycerin; Norpregnenes; Postmenopause; Pulsatile Flow; Regional Blood Flow; Treatment Outcome; Vasodilation | 2005 |
1 other study(ies) available for tibolone and endothelin-1
| Article | Year |
|---|---|
A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women.
Topics: Administration, Cutaneous; Aged; Antioxidants; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelin-1; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Lipids; Middle Aged; Norpregnenes; Postmenopause; Risk Factors | 2002 |